In agreement with a recently published study (7), we confirm the IL8 concentration of 73 ng/L in CSF as a cut-off to differentiate patients with GBS from those with CIDP. This evidence concerns the gene CXCL8 and chronic inflammatory demyelinating polyradiculoneuropathy.